(Q40814496)

English

A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.

scientific article published on November 1985

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2415436%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2415436%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

Hepatitis B virus

1 reference

based on heuristic

inferred from title

Peter Karayiannis

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2415436%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

author name string

A S Lok

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2415436%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

D M Novick

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2415436%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

A A Dunk

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2415436%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

S Sherlock

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2415436%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

H C Thomas

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2415436%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

language of work or name

0 references

publication date

1 November 1985

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2415436%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2415436%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2415436%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2415436%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1132-1138

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2415436%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

21 January 2018

Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

21 January 2018

Spontaneous disappearance of viral replication and liver cell inflammation in HBsAg-positive chronic active hepatitis: results of a placebo vs. interferon trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

21 January 2018

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

21 January 2018

Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

21 January 2018

Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

21 January 2018

Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

7 January 2021

based on heuristic

inferred from DOI database lookup

HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Vidarabine on Chronic Hepatitis B Virus Infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

7 January 2021

based on heuristic

inferred from DOI database lookup

A rapid one-step radiometric assay for hepatitis B surface antigen utilizing monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants for hepatitis B e antigen clearance in chronic type B hepatitis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

7 January 2021

based on heuristic

inferred from DOI database lookup

The Liver Histology and Frequency of Clearance of the Hepatitis B Surface Antigen (HBsAg) in Chronic Carriers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

7 January 2021

based on heuristic

inferred from DOI database lookup

Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

7 January 2021

based on heuristic

inferred from DOI database lookup

Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840050612

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.1840050612

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2415436%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2415436%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40814496&oldid=1507804445"